Buy 4-HO-MiPT 20mg Pellets

Product Overview

4-HO-MiPT 20mg Pellets offer a standardized, unit-dose format of 4-hydroxy-N-methyl-N-isopropyltryptamine (4‑HO‑MiPT, also known as Miprocin), a synthetic tryptamine used as a research analyte and reference material. The pellet form is designed to support consistent mass per unit, simplifying internal documentation, aliquoting, and repeat experimental setups where fixed quantities are required.

4‑HO‑MiPT belongs to the 4‑hydroxytryptamine family and is structurally related to psilocin (4‑HO‑DMT) and other substituted tryptamines, making it relevant for analytical, structural, and comparative research applications. In this configuration it is supplied as a brandless ≥98% purity research chemical, not as a formulated drug or consumer product, and its use is restricted to professional laboratory environments. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

4-HO-MiPT (4-hydroxy-N-methyl-N-isopropyltryptamine) is a synthetic derivative of the substituted tryptamine and 4‑hydroxytryptamine families. It is the 4‑hydroxy analogue of N-methyl-N-isopropyltryptamine (MiPT) and the N‑isopropyl homologue of psilocin (4‑HO‑DMT), sharing the indole-ethylamine scaffold typical of tryptamine compounds.

Key identifiers include:

• Preferred name: 4-hydroxy-N-methyl-N-isopropyltryptamine (4-HO-MiPT)

• Common synonyms: 4-HO-MiPT; Miprocin; 4-hydroxy MiPT; 4-hydroxy-N-isopropyl-N-methyltryptamine

• CAS number: 77872-43-6​

• Molecular formula: C14H20N2O

• Molecular weight: approx. 232.32–232.33 g/mol

• Representative IUPAC-style name: 3-[2-[methyl(propan-2-yl)amino]ethyl]-1H-indol-4-ol​

In a research context, 4‑HO‑MiPT is classified as:

• A synthetic tryptamine research chemical and analytical reference standard.

• A 4‑hydroxy substituted indole derivative used for non-clinical structural, receptor, and analytical studies.

Chemical & Physical Characteristics

Chemical catalogues and monographs describe 4‑HO‑MiPT as a solid organic compound that can be supplied as free base or as crystalline salts (e.g., fumarate or hydrochloride), exhibiting typical properties of 4‑hydroxy tryptamines. The fumarate salt crystal structure has been solved, confirming a protonated tryptammonium cation paired with a hydrogen fumarate anion and water of crystallization.

The compound’s molecular formula C14H20N2O corresponds to a substituted indole with a 4‑hydroxy group and an N‑methyl‑N‑isopropyl ethylamine side chain, affecting its lipophilicity, basicity, and potential for salt formation. Supplier data for 4‑hydroxy MiPT reference standards indicate that it is categorized as a tryptamine and used in rodent head‑twitch response assays, implying compatibility with typical organic solvents used in analytical sample preparation. Pelletized formats are produced by incorporating the compound into solid units engineered to maintain integrity under normal handling and packaging conditions while allowing predictable mass per pellet.

As with many 4‑hydroxy tryptamines, 4‑HO‑MiPT can be chemically sensitive, with reports noting that such compounds may discolor or degrade if not stored under low-temperature, low-oxygen, and light-protected conditions. Specific batch details such as color, physical form, and any observed polymorphism are typically summarized in the certificate of analysis (COA) accompanying research material.

Purity & Analytical Verification

4-HO-MiPT 20mg Pellets are formulated from material specified at ≥98% purity, aligning with research- and reference-grade requirements for tryptamine compounds. High purity is particularly important when the material is used in chromatographic, spectrometric, or quantitative workflows where impurities could confound retention times, spectra, or calibration data.

Analytical verification of 4‑HO‑MiPT typically employs:

• High-performance liquid chromatography (HPLC) or LC‑MS to assess purity and identify impurity peaks.

• Mass spectrometry to confirm molecular ion and characteristic fragment patterns consistent with C14H20N2O.

• NMR and, where available, solid-state studies for structural confirmation of specific salt forms.

Suppliers of 4‑hydroxy MiPT as an analytical reference standard explicitly categorize it as a tryptamine, and provide batch-specific COAs documenting purity and methods used for characterization. Pellet products marketed as high-purity research chemicals similarly highlight compliance with defined purity thresholds and traceable batch documentation.

Quality Control & Batch Integrity

Research suppliers manufacturing 4‑HO‑MiPT pellets employ batch-based production with unique lot identifiers to ensure traceability from initial synthesis through pellet pressing and packaging. Each lot is linked to an internal analytical file including identity verification, purity data, and physical inspection results, which are distilled into a publicly available COA for qualified customers.

Quality control for pelletized research chemicals typically includes:

• Verification that bulk 4‑HO‑MiPT meets or exceeds the specified purity threshold before pellet manufacture.

• Checks on pellet weight uniformity, appearance, and integrity within the defined process tolerances.

• Confirmation that labels, batch codes, and documentation correctly reflect the underlying chemical identity and purity specification.

This structured QC approach helps laboratories maintain consistent input material across experiments, which is especially important when 4‑HO‑MiPT is used as an internal reference or system-suitability compound.

Safety, Handling & Laboratory Precautions

4‑HO‑MiPT is described in technical and encyclopedic sources as a serotonergic psychedelic with activity at multiple serotonin receptors, including 5‑HT2A. This pharmacological profile, while not relevant to the intended use of the product, underlines the need for careful handling, robust containment, and appropriate risk management in research settings.

Standard laboratory precautions include:

• Restricting handling to trained personnel in suitably equipped laboratories.

• Using appropriate PPE (gloves, safety glasses, lab coats) and working in ventilated or controlled environments when manipulating pellets or solutions.

• Avoiding dust or aerosol generation, and preventing uncontrolled release into workspaces or drains.

Researchers should consult the applicable safety data sheet (SDS) for hazard classification, recommended exposure controls, first-aid information, spill-response procedures, and waste-disposal guidance, and must ensure compliance with institutional safety policies and local regulations. No instructions are provided or implied for dosing, administration, or any clinical or personal use.

Packaging, Labeling & Storage

4-HO-MiPT 20mg Pellets are supplied in research-grade containers or blister formats that maintain pellet integrity and protect the compound from environmental factors during shipping and storage. Packaging is intended to be robust and, where applicable, tamper-evident, allowing laboratories to verify that the contents have not been opened or altered prior to receipt.

Labeling typically includes:

• Product designation (4‑HO‑MiPT 20mg Pellets) and core chemical name (4‑hydroxy-N-methyl-N-isopropyltryptamine).

• CAS number (77872‑43‑6), molecular formula C14H20N2O, and lot/batch number.

• Research-use-only wording and any required hazard or precautionary statements.

Technical data for 4‑HO‑MiPT reference material recommend storage at low temperature (commonly around −20 °C), in a tightly closed container and protected from light, to slow degradation and discoloration. Laboratories should follow SDS and COA guidance for storage conditions and re‑test intervals, and restrict access to authorized staff.

Intended Research Use & Market Positioning

4‑HO‑MiPT is used in research as a structurally defined analogue within the broader tryptamine family, relevant to analytical chemistry, receptor-binding studies, and comparative structure–activity analyses. Suppliers emphasize its role as a research chemical or analytical standard, rather than a clinical or consumer product, and note its value for exploring tryptamine-related questions in controlled experimental contexts.

4-HO-MiPT 20mg Pellets are therefore positioned strictly for:

• Analytical and forensic method development and validation.

• Structural and comparative studies within the 4‑hydroxy and N‑isopropyl tryptamine subfamilies.

• Use as an internal reference or research tool where fixed unit quantities are advantageous.

The product is not manufactured, marketed, or suitable for human or veterinary use and is not intended for any clinical, diagnostic, therapeutic, or consumptive application. Any discussion of psychoactive properties in scientific or encyclopedic sources pertains to separate contexts and does not affect the strictly research-only positioning of this material.

Ordering, Availability & Fulfillment

Commercial listings for 4-HO-MiPT 20mg Pellets describe them as high-purity research chemicals in pre-measured pellet form for precise handling in research settings. Suppliers typically limit sales to research customers and clearly identify the material as not for human consumption or therapeutic use.

Order documentation commonly includes:

• Product name and strength (4‑HO‑MiPT 20mg Pellets) alongside core chemical identifiers.

• Lot/batch codes to support internal tracking and quality documentation.

• Access to or provision of COA and SDS upon request for qualified laboratories.

Shipments are usually prepared in discreet, protective outer packaging with tracked delivery options where available, supporting chain-of-custody and inventory control in institutional settings.

Legal & Regulatory Disclaimer

This product is supplied strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional and regulatory oversight. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive applications under any circumstances.

Responsibility for compliance with all applicable local, national, and international laws—including any scheduling, licensing, import/export, and controlled-substance regulations relating to 4‑hydroxy-N‑methyl‑N‑isopropyltryptamine (4‑HO‑MiPT)—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.